• Je něco špatně v tomto záznamu ?

1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy

B. Kaproń, R. Czarnomysy, M. Wysokiński, R. Andrys, K. Musilek, A. Angeli, CT. Supuran, T. Plech,

. 2020 ; 35 (1) : 993-1002. [pub] -

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20027613

There are numerous studies supporting the contribution of oxidative stress to the pathogenesis of epilepsy. Prolonged oxidative stress is associated with the overexpression of ATP-binding cassette transporters, which results in antiepileptic drugs resistance. During our studies, three 1,2,4-triazole-3-thione derivatives were evaluated for the antioxidant activity and anticonvulsant effect in the 6 Hz model of pharmacoresistant epilepsy. The investigated compounds exhibited 2-3 times more potent anticonvulsant activity than valproic acid in 6 Hz test in mice, which is well-established preclinical model of pharmacoresistant epilepsy. The antioxidant/ROS scavenging activity was confirmed in both single-electron transfer-based methods (DPPH and CUPRAC) and during flow cytometric analysis of total ROS activity in U-87 MG cells. Based on the enzymatic studies on human carbonic anhydrases (CAs), acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), one can assume that the herein investigated drug candidates will not impair the cognitive processes mediated by CAs and will have minimal off-target cholinergic effects.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027613
003      
CZ-PrNML
005      
20210114152132.0
007      
ta
008      
210105s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/14756366.2020.1748026 $2 doi
035    __
$a (PubMed)32253957
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kaproń, Barbara $u Department of Clinical Genetics, I Faculty of Medicine with Dentistry Division, Medical University of Lublin, Lublin, Poland.
245    10
$a 1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy / $c B. Kaproń, R. Czarnomysy, M. Wysokiński, R. Andrys, K. Musilek, A. Angeli, CT. Supuran, T. Plech,
520    9_
$a There are numerous studies supporting the contribution of oxidative stress to the pathogenesis of epilepsy. Prolonged oxidative stress is associated with the overexpression of ATP-binding cassette transporters, which results in antiepileptic drugs resistance. During our studies, three 1,2,4-triazole-3-thione derivatives were evaluated for the antioxidant activity and anticonvulsant effect in the 6 Hz model of pharmacoresistant epilepsy. The investigated compounds exhibited 2-3 times more potent anticonvulsant activity than valproic acid in 6 Hz test in mice, which is well-established preclinical model of pharmacoresistant epilepsy. The antioxidant/ROS scavenging activity was confirmed in both single-electron transfer-based methods (DPPH and CUPRAC) and during flow cytometric analysis of total ROS activity in U-87 MG cells. Based on the enzymatic studies on human carbonic anhydrases (CAs), acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), one can assume that the herein investigated drug candidates will not impair the cognitive processes mediated by CAs and will have minimal off-target cholinergic effects.
650    _2
$a acetylcholinesterasa $x metabolismus $7 D000110
650    _2
$a zvířata $7 D000818
650    _2
$a antikonvulziva $x chemická syntéza $x chemie $x farmakologie $7 D000927
650    _2
$a antioxidancia $x chemická syntéza $x chemie $x farmakologie $7 D000975
650    _2
$a bifenylové sloučeniny $x antagonisté a inhibitory $7 D001713
650    _2
$a butyrylcholinesterasa $x metabolismus $7 D002091
650    _2
$a inhibitory karboanhydras $x chemická syntéza $x chemie $x farmakologie $7 D002257
650    _2
$a karboanhydrasy $x metabolismus $7 D002256
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a cholinesterasové inhibitory $x chemická syntéza $x chemie $x farmakologie $7 D002800
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a epilepsie $x farmakoterapie $x metabolismus $7 D004827
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a molekulární modely $7 D008958
650    _2
$a molekulární struktura $7 D015394
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a pikráty $x antagonisté a inhibitory $7 D010851
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a triazoly $x chemická syntéza $x chemie $x farmakologie $7 D014230
655    _2
$a časopisecké články $7 D016428
700    1_
$a Czarnomysy, Robert $u Department of Synthesis and Technology of Drugs, Faculty of Pharmacy, Medical University of Białystok, Bialystok, Poland.
700    1_
$a Wysokiński, Mariusz $u Department of Basic Nursing and Medical Teaching, Chair of Development in Nursing, Faculty of Health Sciences, Medical University of Lublin, Lublin, Poland.
700    1_
$a Andrys, Rudolf $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Musilek, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Angeli, Andrea $u Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Firenze, Italy.
700    1_
$a Supuran, Claudiu T $u Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Firenze, Italy.
700    1_
$a Plech, Tomasz $u Department of Pharmacology, Faculty of Health Sciences, Medical University of Lublin, Lublin, Poland.
773    0_
$w MED00008009 $t Journal of enzyme inhibition and medicinal chemistry $x 1475-6374 $g Roč. 35, č. 1 (2020), s. 993-1002
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32253957 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114152130 $b ABA008
999    __
$a ok $b bmc $g 1607948 $s 1118793
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 35 $c 1 $d 993-1002 $e - $i 1475-6374 $m Journal of enzyme inhibition and medicinal chemistry $n J Enzyme Inhib Med Chem $x MED00008009
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Možnosti archivace